Ziphius
Tuesday, June 04, 2024
Company Presentation
![Immunology](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/immunology.png)
Company Presentation Theater 1
Ziphius is a biotechnology company focused on the development of self-amplifying RNA-based (saRNA) vaccines and therapeutics based on its proprietary saRNA and carrier technology (LNP) platform to allow for a higher and prolonged protein/antigen expression at lower doses (compared to conventional mRNA) with reduced toxicity. This platform has the potential for a ‘plug and play’ approach offering the possibility of fast development/scale-up and production. These attributes makes it well suited as platform to improve pandemic preparedness.
![Ziphius](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1741109-1-JPG.png)
Company Website:
http://www.ziphius.org
Lead Product in Development:
Infectious disease vaccine
Company HQ City
New York
Company HQ State
New York
Company HQ Country
United States
CEO/Top Company Official
Chris Cardon
Development Phase of Primary Product
Pre-Clinical
Speakers